انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
Law & Politics of Drug Price Controls & Pharma Innovation
Manage episode 462068827 series 3579126
This week on IPWatchdog Unleashed we talk about pharmaceutical patents, pharmaceutical patent policy, and innovation.
As you may recall, back in 2022, the Inflation Reduction Act passed. And as part of that law, it gave the federal government the opportunity for the first time to “negotiate” drug prices for Medicare. The Biden Administration has viewed this as fantastic. It has allowed them to control drug prices and drug costs for Medicare. The problem is it's not really a negotiation in any fair sense of the word. What happens is the federal government identifies the drugs on which the U.S. government spends the most amount of money, and then they tell the drug companies that you will either take our offer or you will be fined, and the fines are ruinous—in the billions of dollars. So, the IRA negotiation nothing more than a price fixing, price controlling scheme.
So why is this an issue for us to consider today if the IRA passed in 2022? Literally on the way out the door, last week Health and Human Services identified 15 more drugs that are now going to be forced into this price fixing “negotiation” scheme.
Visit us online at IPWatchdog.com.
You can also visit our channels at YouTube, LinkedIn, X, Instagram and Facebook.
56 حلقات
Manage episode 462068827 series 3579126
This week on IPWatchdog Unleashed we talk about pharmaceutical patents, pharmaceutical patent policy, and innovation.
As you may recall, back in 2022, the Inflation Reduction Act passed. And as part of that law, it gave the federal government the opportunity for the first time to “negotiate” drug prices for Medicare. The Biden Administration has viewed this as fantastic. It has allowed them to control drug prices and drug costs for Medicare. The problem is it's not really a negotiation in any fair sense of the word. What happens is the federal government identifies the drugs on which the U.S. government spends the most amount of money, and then they tell the drug companies that you will either take our offer or you will be fined, and the fines are ruinous—in the billions of dollars. So, the IRA negotiation nothing more than a price fixing, price controlling scheme.
So why is this an issue for us to consider today if the IRA passed in 2022? Literally on the way out the door, last week Health and Human Services identified 15 more drugs that are now going to be forced into this price fixing “negotiation” scheme.
Visit us online at IPWatchdog.com.
You can also visit our channels at YouTube, LinkedIn, X, Instagram and Facebook.
56 حلقات
Todos os episódios
×
1 Patent Monetization: Assessing Today’s Environment and Tomorrow’s Prospects 54:19

1 Gaming Patent Litigation on Both Sides of the "v" 59:35

1 Win for Small Business Patent Owners: Leveling the Patent Litigation Playing Field 54:16


1 Quantum Computers and the Evolution of AI 37:37

1 Patent Blame Game: Are 70% of U.S. Patents Really Defective? 24:09


1 The Existential Threat of AI Consciousness 37:04

1 AI, Quantum and IP: Are We Ready for What’s Next? 54:19

1 AI and the Law: How Companies Can Navigate IP Risk and Seize Opportunity 42:18

1 Fixing the PTAB: 10 Things the USPTO Can do to Improve the PTAB 1:15:35

1 IP, Globalization, and the Future of Supply Chains: A Conversation with Sonja London 42:43

1 Why Creativity & Ownership Are Crucial Ingredients to Innovation 49:28

1 Champions of IP: Judges Michel & Newman 39:26

1 AI, Invention Harvesting and the Patent Backlog 1:02:50
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.